Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-21
DOI
10.1186/s13046-020-01680-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma
- (2019) Xu Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism
- (2019) Sugarniya Subramaniam et al. CLINICAL CHEMISTRY
- Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma
- (2019) Zhi-Fei Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
- (2019) Sebastian Meltzer et al. Translational Oncology
- The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer
- (2019) Xiaoshun Shi et al. Cancer Medicine
- Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs
- (2019) Patrizia Leone et al. Journal of Clinical Medicine
- Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer
- (2018) Chang Li et al. CANCER LETTERS
- Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma
- (2018) Juan Lu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Shedding light on the cell biology of extracellular vesicles
- (2018) Guillaume van Niel et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Targeted Therapy and Immune Therapy for Small Cell Lung Cancer
- (2018) Shirish M. Gadgeel CURRENT TREATMENT OPTIONS IN ONCOLOGY
- The regulatory network of miR-141 in the inhibition of angiogenesis
- (2018) Haojie Dong et al. ANGIOGENESIS
- Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis
- (2018) Zhicheng Zeng et al. Nature Communications
- Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
- (2017) Marcello Tiseo et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
- (2017) Krishnansu S Tewari et al. LANCET
- Tumor angiogenesis revisited: Regulators and clinical implications
- (2017) Roberto Ronca et al. MEDICINAL RESEARCH REVIEWS
- MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis
- (2017) Celia S. L. Mak et al. Molecular Cancer
- Unravelling the biology of SCLC: implications for therapy
- (2017) Joshua K. Sabari et al. Nature Reviews Clinical Oncology
- Krüppel-like factors and vascular wall homeostasis
- (2017) Yanbo Fan et al. Journal of Molecular Cell Biology
- Potential circulating miRNA signature for early detection of NSCLC
- (2017) Ayda Arab et al. Cancer Genetics
- Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer
- (2017) Yun Ye et al. Oncotarget
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
- (2016) R. Rupaimoole et al. Cancer Discovery
- Efficacy and safety of angiogenesis inhibitors in small-cell lung cancer
- (2016) Heng Lin et al. Oncotarget
- Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
- (2015) Lieke H J Simkens et al. LANCET
- Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial
- (2014) Gunter von Minckwitz et al. LANCET ONCOLOGY
- miR-141 and miR-200c as Markers of Overall Survival in Early Stage Non-Small Cell Lung Cancer Adenocarcinoma
- (2014) Rut Tejero et al. PLoS One
- Erlotinib plus Bevacizumab Is Effective in EGFR-Mutant NSCLC
- (2014) Cancer Discovery
- MiR-200, a new star miRNA in human cancer
- (2013) Xiangling Feng et al. CANCER LETTERS
- Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
- (2013) W Kong et al. ONCOGENE
- Tumour angiogenesis regulation by the miR-200 family
- (2013) Chad V. Pecot et al. Nature Communications
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
- (2012) Keun Hur et al. GUT
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells
- (2011) Jing Chen et al. GYNECOLOGIC ONCOLOGY
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- Use of the mouse aortic ring assay to study angiogenesis
- (2011) Marianne Baker et al. Nature Protocols
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- (2011) Hanyin Cheng et al. PLoS One
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started